On the public citation graph

First Pharmacokinetic and Safety Study in Humans of the Novel Lipid Antiviral Conjugate CMX001, a Broad-Spectrum Oral Drug Active against Double-Stranded DNA Viruses

https://doi.org/10.1128/aac.05983-11
0 signed · 188 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/s11095-006-9196-xopenalex-snapshot
Renal Transport of Adefovir, Cidofovir, and Tenofovir by SLC22A Family Members (hOAT1, hOAT3, and hOCT2)
inferredcites →https://doi.org/10.1016/j.antiviral.2009.01.005openalex-snapshot
Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: Current state of the art
inferredcites →https://doi.org/10.1016/s0026-895x(24)23084-4openalex-snapshot
The Antiviral Nucleotide Analogs Cidofovir and Adefovir Are Novel Substrates for Human and Rat Renal Organic Anion Transporter 1
inferredcites →https://doi.org/10.1016/s1083-8791(03)00102-2openalex-snapshot
Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival
inferredcites →https://doi.org/10.1016/s1386-6532(00)00165-7openalex-snapshot
Progress in understanding cytomegalovirus drug resistance
inferredcites →https://doi.org/10.1016/s1474-4422(10)70040-5openalex-snapshot
Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis
inferredcites →https://doi.org/10.1081/ncn-100002341openalex-snapshot
HUMAN RENAL ORGANIC ANION TRANSPORTER 1 (hOAT1) AND ITS ROLE IN THE NEPHROTOXICITY OF ANTIVIRAL NUCLEOTIDE ANALOGS
inferredcites →https://doi.org/10.1086/505498openalex-snapshot
Emerging Infections: Adenovirus Infections in Transplant Recipients
inferredcites →https://doi.org/10.1093/infdis/171.4.788openalex-snapshot
(S)-1-[3-Hydroxy-2-(Phosphonylmethoxy)propyl]cytosine (Cidofovir): Results of a Phase I/II Study of a Novel Antiviral Nucleotide Analogue
inferredcites →https://doi.org/10.1097/00001432-200208000-00002openalex-snapshot
Viral infections in immunocompromised patients: whatʼs new with respiratory viruses?
inferredcites →https://doi.org/10.1097/01.mot.0000186962.26493.31openalex-snapshot
Respiratory viral infections in transplant recipients
inferredcites →https://doi.org/10.1124/mol.63.3.678openalex-snapshot
Increased Antiviral Activity of 1-O-Hexadecyloxypropyl-[2-14C]cidofovir in MRC-5 Human Lung Fibroblasts Is Explained by Unique Cellular Uptake and Metabolism
inferredcites →https://doi.org/10.1128/aac.39.6.1247openalex-snapshot
Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients
inferredcites →https://doi.org/10.1128/cmr.00009-10openalex-snapshot
Antiviral Drug Resistance of Human Cytomegalovirus
inferredcites →https://doi.org/10.1128/cmr.16.4.569-596.2003openalex-snapshot
Clinical Potential of the Acyclic Nucleoside Phosphonates Cidofovir, Adefovir, and Tenofovir in Treatment of DNA Virus and Retrovirus Infections
inferredcites →https://doi.org/10.1358/dof.2008.033.08.1233987openalex-snapshot
CMX001. Anti-smallpox agent, anti-cytomegalovirus agent, viral polymerase inhibitor
inferredcites →https://doi.org/10.2146/ajhp090424openalex-snapshot
Drug interactions and toxicities associated with the antiviral management of cytomegalovirus infection
inferredcites →https://doi.org/10.3390/v2122740openalex-snapshot
Development of CMX001 for the Treatment of Poxvirus Infections

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4656748openalex-extracted
inferred← citeshttps://doi.org/10.1002/9781118416426.ch89openalex-snapshot
Varicella Zoster Virus Infections
inferred← citeshttps://doi.org/10.1002/9781118873434.ch94openalex-snapshot
Late Infectious Disease after Organ Transplantation
inferred← citeshttps://doi.org/10.1002/9781119142812.ch50openalex-snapshot
Herpes Simplex Virus Infections
inferred← citeshttps://doi.org/10.1002/9781444345384.ch48openalex-snapshot
Herpes Simplex Virus Infections
inferred← citeshttps://doi.org/10.1002/acg2.43openalex-snapshot
Viral infections after allogeneic hematopoietic stem cell transplant
inferred← citeshttps://doi.org/10.1002/cpdd.1356openalex-snapshot
Utility of Cytochrome P450 4F2 Genotyping to Assess Drug Interaction Risk for Brincidovovir, a Cytochrome P450 4F2 Substrate
inferred← citeshttps://doi.org/10.1002/phar.2094openalex-snapshot
Brincidofovir as Salvage Therapy for Adenovirus Disease in Intestinal Transplant Recipients
inferred← citeshttps://doi.org/10.1002/rmv.1873openalex-snapshot
Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art
inferred← citeshttps://doi.org/10.1007/7355_2013_28openalex-snapshot
Phosphonated Nucleoside Analogues as Antiviral Agents
inferred← citeshttps://doi.org/10.1007/978-1-4899-7448-8_21openalex-snapshot
Orthopoxviruses: Variola, Vaccinia, Cowpox, and Monkeypox
inferred← citeshttps://doi.org/10.1007/978-1-4939-9034-4_37openalex-snapshot
Cytomegalovirus
inferred← citeshttps://doi.org/10.1007/978-1-4939-9034-4_54openalex-snapshot
Antiviral Consideration for Transplantation Including Drug Resistance
inferred← citeshttps://doi.org/10.1007/978-1-4939-9544-8_21-1openalex-snapshot
Orthopoxviruses: Variola, Vaccinia, Cowpox, and Monkeypox
inferred← citeshttps://doi.org/10.1007/978-3-030-01751-4_33-1openalex-snapshot
Transplant Adenovirus Infection: Clinical Syndromes, Diagnosis, and Management
inferred← citeshttps://doi.org/10.1007/978-3-030-03071-1_3openalex-snapshot
Variola Virus: Clinical, Molecular, and Bioterrorism Perspectives
inferred← citeshttps://doi.org/10.1007/978-3-030-25869-6_33openalex-snapshot
Transplant Adenovirus Infection: Clinical Syndromes, Diagnosis, and Management
inferred← citeshttps://doi.org/10.1007/978-3-030-68321-4_4openalex-snapshot
Mechanisms of Nonretroviral Resistance
inferred← citeshttps://doi.org/10.1007/978-3-031-57369-9_18openalex-snapshot
Antiviral Agents: Cidofovir and Brincidofovir
inferred← citeshttps://doi.org/10.1007/978-3-319-28797-3_33openalex-snapshot
Adenovirus Infection in Allogeneic Stem Cell Transplantation
inferred← citeshttps://doi.org/10.1007/978-3-662-46764-0_155-1openalex-snapshot
Therapie von Infektionen bei Tumorpatienten
inferred← citeshttps://doi.org/10.1007/s00044-021-02766-xopenalex-snapshot
Phosphoryl prodrugs: characteristics to improve drug development
inferred← citeshttps://doi.org/10.1007/s00393-012-0988-6openalex-snapshot
How I treat …
inferred← citeshttps://doi.org/10.1007/s11908-014-0416-yopenalex-snapshot
Adenovirus: Current Epidemiology and Emerging Approaches to Prevention and Treatment
inferred← citeshttps://doi.org/10.1007/s15010-020-01484-7openalex-snapshot
Adenovirus diseases: a systematic review and meta-analysis of 228 case reports
inferred← citeshttps://doi.org/10.1007/s40472-016-0123-8openalex-snapshot
Face Transplantation: Medical Considerations
inferred← citeshttps://doi.org/10.1007/s40506-014-0021-5openalex-snapshot
Cytomegalovirus Treatment
inferred← citeshttps://doi.org/10.1007/s40506-023-00266-7openalex-snapshot
Monkeypox Outbreak: an Overview of Potential Therapeutic Options
inferred← citeshttps://doi.org/10.1016/b978-0-12-815422-9.00004-8openalex-snapshot
DNA-Dependent DNA Polymerases as Drug Targets in Herpesviruses and Poxviruses
inferred← citeshttps://doi.org/10.1016/b978-0-12-818731-9.00139-7openalex-snapshot
Urinary Tract Infections: Virus
inferred← citeshttps://doi.org/10.1016/b978-0-323-40181-4.00210-3openalex-snapshot
Adenoviruses
inferred← citeshttps://doi.org/10.1016/b978-0-323-54841-0.00018-4openalex-snapshot
Therapeutics Overview for Agents of Bioterrorism and Viral Outbreaks
inferred← citeshttps://doi.org/10.1016/b978-0-323-75608-2.00210-xopenalex-snapshot
Adenoviruses
inferred← citeshttps://doi.org/10.1016/b978-0-323-82763-8.00154-0openalex-snapshot
Human Polyomaviruses
inferred← citeshttps://doi.org/10.1016/b978-0-443-22123-1.00008-9openalex-snapshot
Approved and experimental antivirals for mpox
inferred← citeshttps://doi.org/10.1016/b978-0-444-62703-2.00019-7openalex-snapshot
Treating HHV-6 Infections
inferred← citeshttps://doi.org/10.1016/bs.armc.2021.09.001openalex-snapshot
Broad spectrum antiviral nucleosides—Our best hope for the future
inferred← citeshttps://doi.org/10.1016/j.annder.2014.04.114openalex-snapshot
Efficacité et tolérance du cidofovir par voie intraveineuse dans le traitement de molluscums contagiosums géants chez un patient immunodéprimé
inferred← citeshttps://doi.org/10.1016/j.antiviral.2012.11.010openalex-snapshot
Increased susceptibility of Cantagalo virus to the antiviral effect of ST-246®
inferred← citeshttps://doi.org/10.1016/j.antiviral.2015.02.007openalex-snapshot
The efficacy and pharmacokinetics of brincidofovir for the treatment of lethal rabbitpox virus infection: A model of smallpox disease
inferred← citeshttps://doi.org/10.1016/j.antiviral.2018.05.011openalex-snapshot
Genetic diversity of the human adenovirus species C DNA polymerase
inferred← citeshttps://doi.org/10.1016/j.antiviral.2018.08.015openalex-snapshot
In vitro evaluation of current and novel antivirals in combination against human cytomegalovirus
inferred← citeshttps://doi.org/10.1016/j.antiviral.2018.09.003openalex-snapshot
New therapies for human cytomegalovirus infections
inferred← citeshttps://doi.org/10.1016/j.antiviral.2018.12.003openalex-snapshot
Antiviral activity of brincidofovir on parvovirus B19
inferred← citeshttps://doi.org/10.1016/j.antiviral.2024.105799openalex-snapshot
Oral USC-093, a novel homoserinamide analogue of the tyrosinamide (S)-HPMPA prodrug USC-087 has decreased nephrotoxicity while maintaining antiviral efficacy against human adenovirus infection of Syrian hamsters
inferred← citeshttps://doi.org/10.1016/j.antiviral.2024.105995openalex-snapshot
Treatment efficacy of cidofovir and brincidofovir against clade II Monkeypox virus isolates
inferred← citeshttps://doi.org/10.1016/j.bbamem.2016.02.038openalex-snapshot
Functionalized lipids and surfactants for specific applications
inferred← citeshttps://doi.org/10.1016/j.bbmt.2015.12.009openalex-snapshot
Cidofovir in the Treatment of BK Virus–Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
inferred← citeshttps://doi.org/10.1016/j.bbmt.2016.12.621openalex-snapshot
Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial
inferred← citeshttps://doi.org/10.1016/j.bbmt.2018.09.038openalex-snapshot
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation
inferred← citeshttps://doi.org/10.1016/j.bcp.2013.09.010openalex-snapshot
Dancing with chemical formulae of antivirals: A panoramic view (Part 2)
inferred← citeshttps://doi.org/10.1016/j.bioorg.2023.106527openalex-snapshot
Synthesis and anti-SARS-CoV-2 evaluation of lipid prodrugs of β-D-N4-hydroxycytidine (NHC) and a 3′-fluoro-substituted analogue of NHC
inferred← citeshttps://doi.org/10.1016/j.biopha.2024.116558openalex-snapshot
Indirubin-3′-monoxime exhibits potent antiviral and anti-inflammatory effects against human adenoviruses in vitro and in vivo
inferred← citeshttps://doi.org/10.1016/j.bmc.2014.03.031openalex-snapshot
N4-Acyl derivatives as lipophilic prodrugs of cidofovir and its 5-azacytosine analogue, (S)-HPMP-5-azaC: Chemistry and antiviral activity
inferred← citeshttps://doi.org/10.1016/j.clinthera.2018.07.006openalex-snapshot
Antiviral Therapies for Herpesviruses: Current Agents and New Directions
inferred← citeshttps://doi.org/10.1016/j.cmi.2015.03.011openalex-snapshot
Adenovirus infection and disease in paediatric haematopoietic stem cell transplant patients: clues for antiviral pre-emptive treatment
inferred← citeshttps://doi.org/10.1016/j.coviro.2014.06.003openalex-snapshot
Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance
inferred← citeshttps://doi.org/10.1016/j.drudis.2015.07.007openalex-snapshot
Antiadenovirus drug discovery: potential targets and evaluation methodologies
inferred← citeshttps://doi.org/10.1016/j.ejmech.2023.115601openalex-snapshot
Disulfide-incorporated lipid prodrugs of cidofovir: Synthesis, antiviral activity, and release mechanism
inferred← citeshttps://doi.org/10.1016/j.ejphar.2019.172747openalex-snapshot
Selected nucleos(t)ide-based prescribed drugs and their multi-target activity
inferred← citeshttps://doi.org/10.1016/j.jaci.2015.02.015openalex-snapshot
Ebola: A holistic approach is required to achieve effective management and control
inferred← citeshttps://doi.org/10.1016/j.jcv.2012.11.006openalex-snapshot
HDP-CDV as an alternative for treatment of human herpesvirus-6 infections
inferred← citeshttps://doi.org/10.1016/j.semnephrol.2016.05.018openalex-snapshot
Respiratory Viruses: Influenza, RSV, and Adenovirus in Kidney Transplantation
inferred← citeshttps://doi.org/10.1016/j.tox.2018.05.002openalex-snapshot
Transporter-dependent cytotoxicity of antiviral drugs in primary cultures of human proximal tubular cells
inferred← citeshttps://doi.org/10.1016/j.trre.2016.04.001openalex-snapshot
Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations
inferred← citeshttps://doi.org/10.1016/j.vaccine.2023.04.010openalex-snapshot
Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies
inferred← citeshttps://doi.org/10.1016/j.xphs.2016.02.006openalex-snapshot
Enhanced Antitumor Activity of Monophosphate Ester Prodrugs of Gemcitabine: In Vitro and In Vivo Evaluation
inferred← citeshttps://doi.org/10.1016/s1166-8598(16)44729-0openalex-snapshot
10.1016/s1166-8598(16)44729-0
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6b00523openalex-snapshot
Nucleoside Phosphate and Phosphonate Prodrug Clinical Candidates
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.2c00668openalex-snapshot
NPP-669, a Novel Broad-Spectrum Antiviral Therapeutic with Excellent Cellular Uptake, Antiviral Potency, Oral Bioavailability, Preclinical Efficacy, and a Promising Safety Margin
inferred← citeshttps://doi.org/10.1038/524029aopenalex-snapshot
Ebola: Embed research in outbreak response
inferred← citeshttps://doi.org/10.1038/bmt.2015.76openalex-snapshot
Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: What we do and do not know
inferred← citeshttps://doi.org/10.1038/nrd4010openalex-snapshot
Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases
inferred← citeshttps://doi.org/10.1038/s41392-025-02207-wopenalex-snapshot
Novel derivatives of brincidofovir and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine inhibit orthopoxviruses and human adenoviruses more potently than brincidofovir
inferred← citeshttps://doi.org/10.1038/s41467-017-01542-zopenalex-snapshot
The vaccinia virus DNA polymerase structure provides insights into the mode of processivity factor binding
inferred← citeshttps://doi.org/10.1038/s41698-024-00709-4openalex-snapshot
Clinical implications of cytomegalovirus in glioblastoma progression and therapy
inferred← citeshttps://doi.org/10.1039/9781849737814-00081openalex-snapshot
Discovery and Development of Antiviral Drugs for Treatment of Pathogenic Human Orthopoxvirus Infections
inferred← citeshttps://doi.org/10.1055/s-0036-1584793openalex-snapshot
Herpesvirus Respiratory Infections in Immunocompromised Patients: Epidemiology, Management, and Outcomes
inferred← citeshttps://doi.org/10.1056/nejmoa1303688openalex-snapshot
CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation
inferred← citeshttps://doi.org/10.1080/07391102.2023.2216290openalex-snapshot
Machine learning and classical MD simulation to identify inhibitors against the P37 envelope protein of monkeypox virus
inferred← citeshttps://doi.org/10.1080/09273948.2019.1645188openalex-snapshot
Management of Ganciclovir Resistant Cytomegalovirus Retinitis in a Solid Organ Transplant Recipient: A Review of Current Evidence and Treatment Approaches
inferred← citeshttps://doi.org/10.1080/1040841x.2016.1189873openalex-snapshot
45 years after the discovery of human polyomaviruses BK and JC: Time to speed up the understanding of associated diseases and treatment approaches
inferred← citeshttps://doi.org/10.1080/10837450.2019.1694037openalex-snapshot
Lipid–drug conjugates and associated carrier strategies for enhanced antiretroviral drug delivery
inferred← citeshttps://doi.org/10.1080/13543784.2021.1881061openalex-snapshot
Targeting Ebola virus replication through pharmaceutical intervention
inferred← citeshttps://doi.org/10.1080/13543784.2025.2579018openalex-snapshot
Investigational treatments for cytomegalovirus infection in phase I and II study
inferred← citeshttps://doi.org/10.1080/14787210.2017.1266253openalex-snapshot
Treatment of alpha and beta herpesvirus infections in solid organ transplant recipients
inferred← citeshttps://doi.org/10.1080/17460794.2025.2530832openalex-snapshot
Live long and persist: polyomavirus immune evasion in the brain and kidney
inferred← citeshttps://doi.org/10.1080/17474086.2016.1174571openalex-snapshot
Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation
inferred← citeshttps://doi.org/10.1080/17474086.2016.1242406openalex-snapshot
Cytomegalovirus in hematopoietic stem cell transplant recipients - management of infection
inferred← citeshttps://doi.org/10.1080/22221751.2023.2220572openalex-snapshot
Brincidofovir is a robust replication inhibitor against African swine fever virus in vivo and in vitro
inferred← citeshttps://doi.org/10.1080/22221751.2026.2623694openalex-snapshot
Assessment of three antiviral compounds against Borealpox virus infection in a mouse model
inferred← citeshttps://doi.org/10.1093/cid/ciac622openalex-snapshot
Antivirals With Activity Against Mpox: A Clinically Oriented Review
inferred← citeshttps://doi.org/10.1093/cid/civ395openalex-snapshot
Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease
inferred← citeshttps://doi.org/10.1093/femsre/fuz008openalex-snapshot
Drug development against human adenoviruses and its advancement by Syrian hamster models
inferred← citeshttps://doi.org/10.1093/infdis/jiw177openalex-snapshot
Preliminary Evaluation of the Effect of Investigational Ebola Virus Disease Treatments on Viral Genome Sequences
inferred← citeshttps://doi.org/10.1093/jpids/piab072openalex-snapshot
Efficacy of Brincidofovir in Pediatric Stem Cell Transplant Recipients With Adenovirus Infections
inferred← citeshttps://doi.org/10.1093/jpids/pit048openalex-snapshot
Ganciclovir, Foscarnet, and Cidofovir: Antiviral Drugs Not Just for Cytomegalovirus
inferred← citeshttps://doi.org/10.1093/jpids/pit081openalex-snapshot
A Case of Adenovirus Viremia in a Pediatric Liver Transplant Recipient With Neutropenia and Lymphopenia: Who and When Should We Treat?
inferred← citeshttps://doi.org/10.1093/nar/gkw875openalex-snapshot
Distribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymerase
inferred← citeshttps://doi.org/10.1093/ndt/gft036openalex-snapshot
What do we know about adenovirus in renal transplantation?
inferred← citeshttps://doi.org/10.1097/coh.0000000000000007openalex-snapshot
Prodrug strategies for improved efficacy of nucleoside antiviral inhibitors
inferred← citeshttps://doi.org/10.1097/crd.0b013e31828da5b7openalex-snapshot
Adenovirus Infections in Heart Transplantation
inferred← citeshttps://doi.org/10.1097/ftd.0000000000000353openalex-snapshot
Brincidofovir Is Not a Substrate for the Human Organic Anion Transporter 1: A Mechanistic Explanation for the Lack of Nephrotoxicity Observed in Clinical Studies
inferred← citeshttps://doi.org/10.1097/inf.0000000000000678openalex-snapshot
Impact of Adenoviral Stool Load on Adenoviremia in Pediatric Hematopoietic Stem Cell Transplant Recipients
inferred← citeshttps://doi.org/10.1097/ipc.0000000000000545openalex-snapshot
Progressive Multifocal Leukoencephalopathy Treated With CMX001 in a Non–Human Immunodeficiency Virus Patient After Rituximab Therapy for Lymphoma
inferred← citeshttps://doi.org/10.1097/md.0000000000005226openalex-snapshot
Case report
inferred← citeshttps://doi.org/10.1097/mph.0000000000001227openalex-snapshot
Brincidofovir (CMX001) Toxicity Associated With Epithelial Apoptosis and Crypt Drop Out in a Hematopoietic Cell Transplant Patient: Challenges in Distinguishing Drug Toxicity From GVHD
inferred← citeshttps://doi.org/10.1097/qco.0000000000000211openalex-snapshot
Herpes simplex virus and varicella zoster virus
inferred← citeshttps://doi.org/10.1097/tp.0b013e31829df29dopenalex-snapshot
Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation
inferred← citeshttps://doi.org/10.1101/2024.08.30.610570openalex-snapshot
Novel derivatives of BCV and (S)-HPMPA inhibit orthopoxviruses and human adenoviruses more potently than BCV
inferred← citeshttps://doi.org/10.1101/2024.11.01.621456openalex-snapshot
Synthesis of USC-093 and comparison with its promoiety enantiomer USC-093D against adenovirus in vitro and in a Syrian hamster model
inferred← citeshttps://doi.org/10.1111/ajt.12007openalex-snapshot
Human Herpesvirus Vaccines and Future Directions
inferred← citeshttps://doi.org/10.1111/ajt.12013openalex-snapshot
Infections Following Facial Composite Tissue Allotransplantation—Single Center Experience and Review of the Literature
inferred← citeshttps://doi.org/10.1111/ajt.12112openalex-snapshot
Adenovirus in Solid Organ Transplantation
inferred← citeshttps://doi.org/10.1111/apm.12134openalex-snapshot
The human polyomavirus BK ( BKP yV): virological background and clinical implications
inferred← citeshttps://doi.org/10.1111/bph.70258openalex-snapshot
Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovir
inferred← citeshttps://doi.org/10.1111/ctr.13527openalex-snapshot
Adenovirus in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
inferred← citeshttps://doi.org/10.1111/irv.12173openalex-snapshot
Advances in antivirals for non‐influenza respiratory virus infections
inferred← citeshttps://doi.org/10.1111/tid.12582openalex-snapshot
Brincidofovir clearance of acyclovir‐resistant herpes simplex virus‐1 and adenovirus infection after stem cell transplantation
inferred← citeshttps://doi.org/10.1126/sciadv.adg2331openalex-snapshot
Structural basis for the assembly of the DNA polymerase holoenzyme from a monkeypox virus variant
inferred← citeshttps://doi.org/10.1128/9781555819040.ch4openalex-snapshot
Cytomegalovirus
inferred← citeshttps://doi.org/10.1128/9781555819439.ch19openalex-snapshot
Poxviruses
inferred← citeshttps://doi.org/10.1128/aac.00062-13openalex-snapshot
Selection and Recombinant Phenotyping of a Novel CMX001 and Cidofovir Resistance Mutation in Human Cytomegalovirus
inferred← citeshttps://doi.org/10.1128/aac.00214-16openalex-snapshot
Novel Cytomegalovirus UL54 DNA Polymerase Gene Mutations Selected In Vitro That Confer Brincidofovir Resistance
inferred← citeshttps://doi.org/10.1128/aac.00489-24openalex-snapshot
NPP-669, a prodrug of cidofovir, is highly efficacious against human adenovirus infection in the permissive Syrian hamster model
inferred← citeshttps://doi.org/10.1128/mbio.01049-24openalex-snapshot
Brincidofovir inhibits polyomavirus infection in vivo
inferred← citeshttps://doi.org/10.1128/microbiolspec.dmih2-0022-2015openalex-snapshot
Cytomegalovirus
inferred← citeshttps://doi.org/10.1128/msphere.00927-20openalex-snapshot
Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model
inferred← citeshttps://doi.org/10.1146/annurev-pharmtox-010716-105055openalex-snapshot
Will There Be a Cure for Ebola?
inferred← citeshttps://doi.org/10.1155/2013/373579openalex-snapshot
Human Polyomavirus Reactivation: Disease Pathogenesis and Treatment Approaches
inferred← citeshttps://doi.org/10.1155/ipid/2522741openalex-snapshot
Monkeypox: Origin, Transmission, Clinical Manifestations, Prevention, and Therapeutic Options
inferred← citeshttps://doi.org/10.1155/jotm/6688914openalex-snapshot
From Outbreaks to Artificial Intelligence: A Comprehensive Review of Monkeypox Virus Epidemiology, Diagnosis, Treatment, Vaccination, and Deep Learning Applications
inferred← citeshttps://doi.org/10.1159/000491705openalex-snapshot
Octadecyloxyethyl Adefovir Exhibits Potent in vitro and in vivo Cytotoxic Activity and Has Synergistic Effects with Ara-C in Acute Myeloid Leukemia
inferred← citeshttps://doi.org/10.1177/1060028014561227openalex-snapshot
Potential and Emerging Treatment Options for Ebola Virus Disease
inferred← citeshttps://doi.org/10.1177/10600280231151751openalex-snapshot
Brincidofovir: A Novel Agent for the Treatment of Smallpox
inferred← citeshttps://doi.org/10.1182/blood-2016-06-688432openalex-snapshot
How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients
inferred← citeshttps://doi.org/10.1186/s43556-024-00226-7openalex-snapshot
Human cytomegalovirus: pathogenesis, prevention, and treatment
inferred← citeshttps://doi.org/10.1358/dof.2013.038.05.1946425openalex-snapshot
Letermovir
inferred← citeshttps://doi.org/10.1371/journal.pone.0139001openalex-snapshot
Structural Analysis of Monomeric RNA-Dependent Polymerases: Evolutionary and Therapeutic Implications
inferred← citeshttps://doi.org/10.1371/journal.pone.0162199openalex-snapshot
Experimental Treatment of Ebola Virus Disease with Brincidofovir
inferred← citeshttps://doi.org/10.1517/21678707.2013.842166openalex-snapshot
Prevention of cytomegalovirus disease in patients with impaired cell-mediated immunity – is there a need for maribavir?
inferred← citeshttps://doi.org/10.1586/14787210.2013.836964openalex-snapshot
Diagnosis and treatment of adenovirus infection in immunocompromised patients
inferred← citeshttps://doi.org/10.1586/14787210.2014.948847openalex-snapshot
Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses
inferred← citeshttps://doi.org/10.1586/14787210.2016.1132162openalex-snapshot
Treatment options for progressive multifocal leukoencephalopathy in HIV-infected persons: current status and future directions
inferred← citeshttps://doi.org/10.18524/2307-4663.2016.4(36).86796openalex-snapshot
ANTIADENOVIRALACTIVITY OF FLUORIDECONTAINING NUCLEOSIDES AND BISPHOSPHONATES DERIVATES
inferred← citeshttps://doi.org/10.18821/0507-4088-2018-63-5-202-211openalex-snapshot
MODERN ETHIOTROPIC CHEMOTHERAPY OF HUMAN CYTOMEGALOVIRUS INFECTION: CLINICAL EFFECTIVENESS, MOLECULAR MECHANISM OF ACTION, DRUG RESISTANCE, NEW TRENDS AND PROSPECTS. PART 1
inferred← citeshttps://doi.org/10.21203/rs.3.rs-2381680/v1openalex-snapshot
An in silico investigation and introduction of some secondary metabolites of medicinal plants with antiviral activity and effective vitamins for the treatment of MPox
inferred← citeshttps://doi.org/10.21926/obm.transplant.1903081openalex-snapshot
Viral Infections in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Literature Review
inferred← citeshttps://doi.org/10.2217/fmb-2019-0288openalex-snapshot
Brincidofovir: Understanding its Unique Profile and Potential Role Against Adenovirus and Other Viral Infections
inferred← citeshttps://doi.org/10.2217/fvl.13.76openalex-snapshot
Orthopoxvirus Inhibitors that are Active in Animal Models: An Update from 2008 to 2012
inferred← citeshttps://doi.org/10.32388/h2zntuopenalex-snapshot
Novel Derivatives of BCV and (S)-HPMPA Inhibit Orthopoxviruses and Human Adenoviruses More Potently Than BCV
inferred← citeshttps://doi.org/10.32388/h2zntu.2openalex-snapshot
Novel Derivatives of BCV and (S)-HPMPA Inhibit Orthopoxviruses and Human Adenoviruses More Potently Than BCV
inferred← citeshttps://doi.org/10.3389/fchem.2020.616863openalex-snapshot
Overview of Biologically Active Nucleoside Phosphonates
inferred← citeshttps://doi.org/10.3389/fcimb.2018.00408openalex-snapshot
Disseminated Adenovirus Infection After Combined Liver-Kidney Transplantation
inferred← citeshttps://doi.org/10.3389/fmicb.2023.1321116openalex-snapshot
Anti-CMV therapy, what next? A systematic review
inferred← citeshttps://doi.org/10.3389/fped.2025.1552958openalex-snapshot
Research progress on human adenovirus sepsis
inferred← citeshttps://doi.org/10.3390/biomedicines11020278openalex-snapshot
Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects
inferred← citeshttps://doi.org/10.3390/v11070659openalex-snapshot
Advances in the Development of Antiviral Strategies against Parvovirus B19
inferred← citeshttps://doi.org/10.3390/v15020330openalex-snapshot
An Old Acquaintance: Could Adenoviruses Be Our Next Pandemic Threat?
inferred← citeshttps://doi.org/10.3390/v16071085openalex-snapshot
Refractory/Resistant Cytomegalovirus Infection in Transplant Recipients: An Update
inferred← citeshttps://doi.org/10.3390/v16081200openalex-snapshot
Longitudinal Monitoring of the Effects of Anti-Adenoviral Treatment Regimens in a Permissive In Vivo Model
inferred← citeshttps://doi.org/10.3390/v6114731openalex-snapshot
KSHV Targeted Therapy: An Update on Inhibitors of Viral Lytic Replication
inferred← citeshttps://doi.org/10.3410/f.726995359.793545904openalex-snapshot
Faculty Opinions recommendation of Case report: Brincidofovir-induced reversible severe acute kidney injury in 2 solid-organ transplant for treatment of cytomegalovirus infection.
inferred← citeshttps://doi.org/10.3748/wjg.v20.i31.10658openalex-snapshot
Cytomegalovirus infection in liver transplant recipients: Updates on clinical management
inferred← citeshttps://doi.org/10.3892/ol.2021.12579openalex-snapshot
Human cytomegalovirus infection: A considerable issue following allogeneic hematopoietic stem cell transplantation (Review)
inferred← citeshttps://doi.org/10.3918/jsicm.26_5openalex-snapshot
Cytomegalovirus infection in immunocompetent critically ill patients
inferred← citeshttps://doi.org/10.4103/ijot.ijot_38_18openalex-snapshot
Viral nephropathies in renal transplantation with a special emphasis on adenovirus infection
inferred← citeshttps://doi.org/10.4254/wjh.v6.i6.370openalex-snapshot
Management of cytomegalovirus infection and disease in liver transplant recipients
inferred← citeshttps://doi.org/10.6061/clinics/2014(sup01)03openalex-snapshot
New immunosuppressive agents in pediatric transplantation
inferred← citeshttps://doi.org/10.7759/cureus.5296openalex-snapshot
Brincidofovir (CMX001) for the Treatment of Severe Adenoviral Pneumonia in Kidney Transplant Recipient
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.